Skip to content
Independent analysis of NHS open data
PharmaInsight

Dolutegravir/rilpivirine vs Entecavir

National NHS prescribing compared (Prescription Cost Analysis)
Data updated March 2026

Entecavir was dispensed 279.0× as often as Dolutegravir/rilpivirine in March 2026 — 279 items versus 1 in England.

1items

Dolutegravir/rilpivirine · March 2026

NHSBSA Prescription Cost Analysis

279items

Entecavir · March 2026

NHSBSA Prescription Cost Analysis

Figure 1. Dolutegravir/rilpivirine versus Entecavir: national items dispensed by month

▬ Dolutegravir/rilpivirine   ·   ╌ Entecavir

0 150 300 Jan 2021 Oct 2023 Jan 2024 May 2024 Aug 2024 Dec 2024 Mar 2026 Entecavir 1 Jan 2021: 1 Mar 2021: 2 Aug 2022: 1 Oct 2023: 1 Nov 2023: 1 Dec 2023: 2 Jan 2024: 1 Mar 2024: 1 Apr 2024: 1 May 2024: 3 Jun 2024: 1 Jul 2024: 1 Aug 2024: 1 Sep 2024: 1 Nov 2024: 2 Dec 2024: 1 Jan 2025: 2 Sep 2025: 1 Mar 2026: 1

Source: NHSBSA Prescription Cost Analysis, to March 2026

Dolutegravir/rilpivirine versus Entecavir, March 2026
Measure Dolutegravir/rilpivirine Entecavir
Items, March 2026 1 279
Items, last 12 months 16 3,325
Net ingredient cost, March 2026 £699 £138,668

See the full profile for Dolutegravir/rilpivirine or Entecavir.